Skip to main content
OpenTrials
Completed

NCT Number: NCT00300066

Assessment of Serum Cystatin C as a Marker of Kidney Function in Children

The purpose of this study is to assess serum cystatin C as a marker of kidney function (glomerular filtration rate, GFR) in children aged 2-14. The individual production rate and possible extra renal elimination of cystatin C based on body composition data is included to develop new algorithms to estimate GFR.

Furthermore, day-to-day variation on serum cystatin C is investigated.

Completed

Looking for future studies?

Notify Me

Key information

Age range

2 year–14 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Nuclear Medicine, University Hospital Aarhus, Skejby, Aarhus, Brendstrupgaardsvej 100, Denmark

Loading trial locations.

About this study

Today, children's kidney function (glomerular filtration rate, GFR) can be monitored by two methods:

  • indirectly by serum creatinine, or
  • directly by injection of a radioactive substance followed by several blood samples.

The first method is inaccurate with many drawbacks, whereas the latter is precise but time-consuming and unpleasant for the child. Therefore, there is a need for a new method for investigating GFR in children.

Serum cystatin C is a small protein that is produced with a constant rate in all nucleated cells in the body. It meets many of the characteristics of an ideal marker of GFR because of the way it is excreted in the kidneys. However, earlier studies have not proven serum cystatin C to be convincingly better than serum creatinine. Why? If there is considerable extra renal elimination, serum cystatin C alone isn't enough to estimate GFR. Therefore, the individual production rate and possible extra renal elimination of cystatin C are included in this study. To assess these factors, the children are submitted to bioelectrical impedance spectroscopy (BIS) to estimate their body composition, including body cell mass as cystatin C is produced in all nucleated cells. To validate the BIS data, dual energy x-ray absorptiometry (DEXA) will be conducted on 100 of the included children.

Based on serum cystatin C and the individual, age-corrected extra renal elimination rate of cystatin C, new algorithms to calculate GFR can be developed.

Furthermore, day-to-day variation in serum cystatin C and BIS data, which is expected to be low, is investigated in 100 of the included children.

Hypotheses:

  • Day-to-day variation on serum cystatin C is low.
  • Serum cystatin C raises parallel to falling GFR with time, which means that serum cystatin C can be used to monitor changes in kidney function in each patient.
  • Based on body composition, regression analysis and serum cystatin C values, GFR can be estimated in children aged 2-14.
  • GFR calculated as stated above is a more precise measurement of kidney function and changes in kidney function than GFR estimated from serum creatinine.
  • Data of body composition estimated by BIS do not deviate from data estimated by DEXA
  • Day-to-day variation in data for body composition measured by BIS is low.

The project includes 200 children aged 2-14 who are referred for routine examination of GFR in two Departments of Nuclear Medicine.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 2-14 years referred for GFR measurement by 51-CrEDTA

Exclusion criteria

  • GFR measurement by capillary technique
  • Immune compromising treatment
  • Previous kidney transplant
  • Hypo- or hyperthyroidism
  • Increased C-reactive protein (CRP)
  • Rheumatoid arthritis
  • Ascites
  • Pacemaker (only exclusion for BIS and DEXA)

Sponsors and collaborators

Lead sponsor

Aalborg University Hospital

Other

Collaborators

  • Aarhus University Hospital

Registry information

Official study title

Prediction Equations for Glomerular Filtration Rate in Children Based on Serum Cystatin C and Body Cell Mass

Important dates

Study start
2006
Primary completion
2008
Study completion
2008
First posted
Mar 8, 2006
Registry last updated
May 28, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.